The association of pre-conization high-risk HPV load and the persistence of HPV infection and persistence/recurrence of cervical intraepithelial neoplasia after conization

Gynecologic Oncology

Volumn 108, Issue 3, 2008, Pages 549-554

  Park, Jeong Yeol ^a   Lee, Kyung Hee ^b   Dong, Seung Myung ^a   Kang, Sokbom ^a   Park, Sang Yoon ^a   Seo, Sang Soo ^a  

^a National Cancer Center   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Conization; High risk HPV; Load; Persistence; Recurrence

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CONTROLLED STUDY; CYTOLOGY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK FACTOR; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CONIZATION; VIRUS INFECTION; VIRUS LOAD; WART VIRUS;

EID: 39549092125     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2007.11.009     Document Type: Article

References (38)

1. Kucera E., Sliutz G., Czerwenka K., Breitenecker G., Leodolter S., and Reinthaller A. Is high-risk human papillomavirus infection associated with cervical intraepithelial neoplasia eliminated after conization by large-loop excision of the transformation zone?. Eur J Obstet Gynecol Reprod Biol 100 (2001) 72-76
2. Nagai Y., Maehama T., Asato T., and Kanazawa K. Persistence of human papillomavirus infection after therapeutic conization for CIN 3: is it an alarm for disease recurrence?. Gynecol Oncol 79 (2000) 294-299
3. Chao A., Lin C.T., Hsueh S., Chou H.H., Chang T.C., Chen M.Y., and Lai C.H. Usefulness of human papillomavirus testing in the follow-up of patients with high-grade cervical intraepithelial neoplasia after conization. Am J Obstet Gynecol 190 (2004) 1046-1051
4. Jain S., Tseng C.J., Horng S.G., Soong Y.K., and Pao C.C. Negative predictive value of human papillomavirus test following conization of the cervix uteri. Gynecol Oncol 82 (2001) 177-180
5. Kanamori Y., Kigawa J., Minagawa Y., Irie T., Oishi T., Itamochi H., et al. Residual disease and presence of human papillomavirus after conization. Oncology 55 (1998) 517-520
6. Lin C.T., Tseng C.J., Lai C.H., Hsueh S., Huang K.G., Huang H.J., et al. Value of human papillomavirus deoxyribonucleic acid testing after conization in the prediction of residual disease in the subsequent hysterectomy specimen. Am J Obstet Gynecol 184 (2001) 940-945
7. Hernadi Z., Szoke K., Sapy T., Krasznai Z.T., Soos G., Veress G., et al. Role of human papillomavirus (HPV) testing in the follow-up of patients after treatment for cervical precancerous lesions. Eur J Obstet Gynecol Reprod Biol 118 (2005) 229-234
8. Josefsson A.M., Magnusson P.K., Ylitalo N., Sorensen P., Qwarforth-Tubbin P., Andersen P.K., et al. Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study. Lancet 355 (2000) 2189-2193
9. Sun C.A., Lai H.C., Chang C.C., Neih S., Yu C.P., and Chu T.Y. The significance of human papillomavirus viral load in prediction of histologic severity and size of squamous intraepithelial lesions of uterine cervix. Gynecol Oncol 83 (2001) 95-99
10. Ylitalo N., Sorensen P., Josefsson A.M., Magnusson P.K., Andersen P.K., Ponten J., et al. Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study. Lancet 355 (2000) 2194-2198
11. Ho G.Y., Burk R.D., Klein S., Kadish A.S., Chang C.J., Palan P., et al. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 87 (1995) 1365-1371
12. Mitchell M.F., Hittelman W.N., Hong W.K., Lotan R., and Schottenfeld D. The natural history of cervical intraepithelial neoplasia: an argument for intermediate endpoint biomarkers. Cancer Epidemiol Biomarkers Prev 3 (1994) 619-626
13. Ostor A.G. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol 12 (1993) 186-192
14. Lin H., Chang H.Y., Huang C.C., and Changchien C.C. Prediction of disease persistence after conization for microinvasive cervical carcinoma and cervical intraepithelial neoplasia grade 3. Int J Gynecol Cancer 14 (2004) 311-316
15. Moore B.C., Higgins R.V., Laurent S.L., Marroum M.C., and Bellitt P. Predictive factors from cold knife conization for residual cervical intraepithelial neoplasia in subsequent hysterectomy. Am J Obstet Gynecol 173 (1995) 361-366 [discussion 366-8]
16. Lu C.H., Liu F.S., Tseng J.J., and Ho ES. Predictive factors for residual disease in subsequent hysterectomy following conization for CIN III. Gynecol Oncol 79 (2000) 284-288
17. Husseinzadeh N., Shbaro I., and Wesseler T. Predictive value of cone margins and post-cone endocervical curettage with residual disease in subsequent hysterectomy. Gynecol Oncol 33 (1989) 198-200
18. Jones III H.W., and Buller R.E. The treatment of cervical intraepithelial neoplasia by cone biopsy. Am J Obstet Gynecol 137 (1980) 882-886
19. Lapaquette T.K., Dinh T.V., Hannigan E.V., Doherty M.G., Yandell R.B., and Buchanan V.S. Management of patients with positive margins after cervical conization. Obstet Gynecol 82 (1993) 440-443
20. Paterson-Brown S., Chappatte O.A., Clark S.K., Wright A., Maxwell P., Taub N.A., et al. The significance of cone biopsy resection margins. Gynecol Oncol 46 (1992) 182-185
21. Phelps III J.Y., Ward J.A., Szigeti II J., Bowland C.H., and Mayer A.R. Cervical cone margins as a predictor for residual dysplasia in post-cone hysterectomy specimens. Obstet Gynecol 84 (1994) 128-130
22. Livasy C.A., Maygarden S.J., Rajaratnam C.T., and Novotny D.B. Predictors of recurrent dysplasia after a cervical loop electrocautery excision procedure for CIN-3: a study of margin, endocervical gland, and quadrant involvement. Mod Pathol 12 (1999) 233-238
23. Costa S., De Simone P., Venturoli S., Cricca M., Zerbini M.L., Musiani M., et al. Factors predicting human papillomavirus clearance in cervical intraepithelial neoplasia lesions treated by conization. Gynecol Oncol 90 (2003) 358-365
24. Dalstein V., Riethmuller D., Pretet J.L., Le Bail Carval K., Sautiere J.L., Carbillet J.P., et al. Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study. Int J Cancer 106 (2003) 396-403
25. Franco E.L., Villa L.L., Sobrinho J.P., Prado J.M., Rousseau M.C., Desy M., et al. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. J Infect Dis 180 (1999) 1415-1423
26. Nobbenhuis M.A., Helmerhorst T.J., van den Brule A.J., Rozendaal L., Voorhorst F.J., Bezemer P.D., et al. Cytological regression and clearance of high-risk human papillomavirus in women with an abnormal cervical smear. Lancet 358 (2001) 1782-1783
27. Sarian L.O., Derchain S.F., Pitta Dda R., Morais S.S., and Rabelo-Santos SH. Factors associated with HPV persistence after treatment for high-grade cervical intra-epithelial neoplasia with large loop excision of the transformation zone (LLETZ). J Clin Virol 31 (2004) 270-274
28. Clavel C., Cucherousset J., Lorenzato M., Caudroy S., Nou J.M., Nazeyrollas P., et al. Negative human papillomavirus testing in normal smears selects a population at low risk for developing high-grade cervical lesions. Br J Cancer 90 (2004) 1803-1808
29. Nobbenhuis M.A., Walboomers J.M., Helmerhorst T.J., Rozendaal L., Remmink A.J., Risse E.K., et al. Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet 354 (1999) 20-25
30. Alonso I., Torne A., Puig-Tintore L.M., Esteve R., Quinto L., Campo E., et al. Pre- and post-conization high-risk HPV testing predicts residual/recurrent disease in patients treated for CIN 2-3. Gynecol Oncol 103 (2006) 631-636
31. Song S.H., Lee J.K., Oh M.J., Hur J.Y., Na J.Y., Park Y.K., et al. Persistent HPV infection after conization in patients with negative margins. Gynecol Oncol 101 (2006) 418-422
32. Kreimer A.R., Guido R.S., Solomon D., Schiffman M., Wacholder S., Jeronimo J., et al. Human papillomavirus testing following loop electrosurgical excision procedure identifies women at risk for posttreatment cervical intraepithelial neoplasia grade 2 or 3 disease. Cancer Epidemiol Biomarkers Prev 15 (2006) 908-914
33. Hernandez-Hernandez D.M., Ornelas-Bernal L., Guido-Jimenez M., Apresa-Garcia T., Alvarado-Cabrero I., Salcedo-Vargas M., et al. Association between high-risk human papillomavirus DNA load and precursor lesions of cervical cancer in Mexican women. Gynecol Oncol 90 (2003) 310-317
34. Almog B., Gamzu R., Kuperminc M.J., Levin I., Fainaru O., Niv J., et al. Human papilloma virus testing in patient follow-up post cone biopsy due to high-grade cervical intraepithelial neoplasia. Gynecol Oncol 88 (2003) 345-350
35. Sherman M.E., Wang S.S., Wheeler C.M., Rich L., Gravitt P.E., Tarone R., et al. Determinants of human papillomavirus load among women with histological cervical intraepithelial neoplasia 3: dominant impact of surrounding low-grade lesions. Cancer Epidemiol Biomarkers Prev 12 (2003) 1038-1044
36. Tsai H.T., Wu C.H., Lai H.L., Li R.N., Tung Y.C., Chuang H.Y., et al. Association between quantitative high-risk human papillomavirus DNA load and cervical intraepithelial neoplasm risk. Cancer Epidemiol Biomarkers Prev 14 (2005) 2544-2549
37. Crum C.P., Nagai N., Levine R.U., and Silverstein S. In situ hybridization analysis of HPV 16 DNA sequences in early cervical neoplasia. Am J Pathol 123 (1986) 174-182
38. Schneider A., Oltersdorf T., Schneider V., and Gissmann L. Distribution pattern of human papilloma virus 16 genome in cervical neoplasia by molecular in situ hybridization of tissue sections. Int J Cancer 39 (1987) 717-721